Focused Wealth Management, Inc - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$4,539
-19.1%
1000.0%0.00%0.0%
Q2 2023$5,614
+24.1%
1000.0%0.00%0.0%
Q1 2023$4,523
+11.3%
1000.0%0.00%0.0%
Q4 2022$4,065
-93.1%
100
-88.9%
0.00%
-91.7%
Q3 2022$59,000
+883.3%
900
+800.0%
0.01%
+1100.0%
Q2 2022$6,0000.0%1000.0%0.00%0.0%
Q1 2022$6,000
-25.0%
1000.0%0.00%0.0%
Q4 2021$8,000
-27.3%
1000.0%0.00%
-50.0%
Q3 2021$11,000
-31.2%
1000.0%0.00%
-33.3%
Q2 2021$16,000
+33.3%
1000.0%0.00%
+50.0%
Q1 2021$12,000
-20.0%
1000.0%0.00%
-33.3%
Q4 2020$15,000
+15.4%
100
-33.3%
0.00%0.0%
Q3 2020$13,000
-13.3%
150
-25.0%
0.00%0.0%
Q2 2020$15,000
+87.5%
2000.0%0.00%
+50.0%
Q1 2020$8,000
-33.3%
2000.0%0.00%
-33.3%
Q4 2019$12,000
+50.0%
2000.0%0.00%
+50.0%
Q3 2019$8,000
-11.1%
2000.0%0.00%0.0%
Q2 2019$9,000
+28.6%
2000.0%0.00%0.0%
Q1 2019$7,000
+16.7%
2000.0%0.00%0.0%
Q4 2018$6,000
-33.3%
2000.0%0.00%
-33.3%
Q3 2018$9,000
-25.0%
2000.0%0.00%
-25.0%
Q2 2018$12,000
+33.3%
2000.0%0.00%
+33.3%
Q1 2018$9,0002000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$31,294,00031.24%
NEA Management Company, LLC 1,590,002$365,593,00010.56%
Ariose Capital Management Ltd 37,900$2,379,0009.30%
ARK Investment Management 9,404,071$590,294,0002.46%
NIA IMPACT ADVISORS, LLC 80,082$5,027,0002.44%
Nikko Asset Management Americas, Inc. 4,619,747$291,044,0002.14%
PLUSTICK MANAGEMENT LLC 50,000$3,139,0001.98%
Integral Health Asset Management, LLC 120,000$7,532,0001.96%
Valiant Capital Management, L.P. 240,683$15,108,0001.73%
Deuterium Capital Management, LLC 18,000$1,130,0001.45%
View complete list of CRISPR THERAPEUTICS AG shareholders